BRIEF published on 02/19/2025 at 22:10, 1 year 4 months ago Bausch Health Reports Strong Financial Performance in 2024 Adjusted EBITDA Revenue Growth Financial Performance Bausch Health 2024 Results
PRESS RELEASE published on 02/19/2025 at 22:05, 1 year 4 months ago Bausch Health Announces Fourth Quarter and Full-Year 2024 Results Bausch Health Companies Inc. announces strong Q4 and full-year 2024 financial results, achieving revenue growth in all segments and exceeding adjusted EBITDA guidance Financial Results Adjusted EBITDA Revenue Growth Bausch Health Q4 2024
BRIEF published on 02/14/2025 at 14:05, 1 year 4 months ago Bausch Health participera à la conférence financière de JP Morgan Webcast Soins De Santé Bausch Santé Pharmaceutique Conférence Sur Les Finances
BRIEF published on 02/14/2025 at 14:05, 1 year 4 months ago Bausch Health to Attend J.P. Morgan Finance Conference Healthcare Pharmaceutical Webcast Bausch Health Finance Conference
PRESS RELEASE published on 02/14/2025 at 14:00, 1 year 4 months ago Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference Bausch Health Companies Inc. to participate in 2025 J.P. Morgan Global Leveraged Finance Conference on February 24. Webcast available on Investor Relations section of Bausch Health's website Investor Relations Webcast Conference Bausch Health J.P. Morgan
BRIEF published on 02/10/2025 at 14:05, 1 year 4 months ago Bausch Health Launches 2025 Salix GI Health Scholars Program Salix Pharmaceuticals Bausch Health Higher Education GI Diseases Scholarship Program
BRIEF published on 02/10/2025 at 14:05, 1 year 4 months ago Bausch Health lance le programme de bourses d'études Salix GI Health 2025 Bausch Santé Enseignement Supérieur Programme De Bourses D'études Produits Pharmaceutiques Salix Maladies Gastro-intestinales
PRESS RELEASE published on 02/10/2025 at 14:00, 1 year 4 months ago Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program Bausch Health and Salix Pharmaceuticals launch 2025 Salix Gastrointestinal Health Scholars Program, offering scholarships for students living with GI diseases. Application deadline on May 5, 2025 Salix Pharmaceuticals Bausch Health Scholarships GI Diseases 2025
BRIEF published on 02/06/2025 at 13:10, 1 year 4 months ago Bausch Health Decides Against Sale of Bausch + Lomb Financial Performance Bausch Health Liability Management Bausch + Lomb Sale Decision
BRIEF published on 02/06/2025 at 13:10, 1 year 4 months ago Bausch Health décide de ne pas vendre Bausch + Lomb Performance Financière Bausch Santé Bausch + Lomb Décision De Vente Gestion De La Responsabilité
Published on 06/27/2026 at 16:50, 7 hours 39 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 22 hours 49 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 1 hour ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 1 hour ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 1 day ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 1 day 1 hour ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
